
Xcell Therapeutics Inc. — Investor Relations & Filings
Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 기업설명회(IR)개최 | 2026-04-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | |
| [기재정정]주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46348401 | [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | ||
| 46348392 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34546589 | 기업설명회(IR)개최 | 2026-04-15 | Korean | ||
| 33135306 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33135251 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33129738 | [기재정정]주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | ||
| 33129688 | 주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | ||
| 33129656 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33084598 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-30 | Korean | ||
| 33084339 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-30 | Korean | ||
| 33058275 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33057987 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33055592 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 32996034 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-20 | Korean | ||
| 32984488 | 감사보고서제출 | 2026-03-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Xcell Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16801/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16801 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16801 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16801 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16801}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xcell Therapeutics Inc. (id: 16801)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.